QuidelOrtho Appoints Erich Wolff as New Corporate Leader
QuidelOrtho Announces New Executive Vice President
QuidelOrtho Corporation (Nasdaq: QDEL), a leader in the field of in vitro diagnostics, is excited to announce the appointment of Erich Wolff as the Executive Vice President for Strategy & Corporate Development. In his new role, Mr. Wolff will directly report to Brian Blaser, the President and CEO, guiding the company’s enterprise strategy, business development, government affairs, and management of the portfolio.
Experience and Background of Erich Wolff
Bringing over 20 years of experience in leadership roles, Erich Wolff has a rich history in strategy, mergers and acquisitions, and business development within healthcare, diagnostics, and MedTech industries. His most recent position was at Partners Group, where he led buyouts for MedTech and Life Sciences Tools & Diagnostics, overseeing a substantial portfolio worth $174 billion.
Before this role, Mr. Wolff held significant positions at BD and Medtronic, where he was a driving force behind transformational initiatives that included corporate strategy, investment planning, and growth through acquisitions.
Comments from Leadership
Brian Blaser, the President and CEO of QuidelOrtho, expressed enthusiasm about the new addition to his team, stating, "Erich brings a rare combination of strategic vision, operational rigor and transaction expertise. His unique ability to manage complex portfolio decisions and implement impactful growth strategies will be crucial as we strive to enhance diagnostics’ power for a healthier future."
Achievements at Medtronic and BD
During his tenure at Medtronic, Mr. Wolff played a pivotal role in revitalizing the global diabetes business and took on greater responsibilities involving corporate development in the lucrative neurosciences and diabetes sectors, together worth approximately $11.5 billion. At BD, he was integral to significant milestones such as the spinoff of embecta and the acquisition of Parata Systems valued at $1.5 billion, as well as the divestiture of the Surgical Instrumentation platform.
Vision for the Future
In his own words, Mr. Wolff remarked, "I am honored to join QuidelOrtho at such a critical juncture. The Company possesses a compelling vision for the future of diagnostics, an established global presence and an innovative culture. I am eager to collaborate with Brian and the leadership team to craft and implement strategies that accelerate growth and yield long-term value for our stakeholders."
Educational Background
Mr. Wolff earned a Bachelor of Business Administration with a focus on Finance and Economics from the University of Wisconsin–Milwaukee, equipping him with the foundational knowledge that underpins his extensive career in business leadership.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is recognized as a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that convert data into actionable insights, empowering individuals and professionals across different regions daily. By leveraging its industry-leading expertise in immunoassay, molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho ensures fast, reliable diagnostics where they are needed most – from homes to hospitals and clinics.
With a strong foundation of innovation, QuidelOrtho collaborates with healthcare providers globally to uplift diagnostics and illuminate clearer pathways for informed decision-making.
Investor and Media Contact Information
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
Frequently Asked Questions
Who has been appointed as the new EVP at QuidelOrtho?
QuidelOrtho has appointed Erich Wolff as the new Executive Vice President of Strategy & Corporate Development.
What experience does Erich Wolff bring to his new role?
Mr. Wolff has over two decades of leadership experience across strategy, mergers and acquisitions, and business development in the healthcare and diagnostics sectors.
What were some of Erich Wolff's achievements at Medtronic?
At Medtronic, Mr. Wolff revitalized the global diabetes business and oversaw corporate development for the neurosciences and diabetes sectors, managing a substantial portfolio.
What is QuidelOrtho's vision for the future?
The company aims to advance diagnostics and deliver long-term value to stakeholders, leveraging its innovative culture and global presence.
Where can I find more information about QuidelOrtho?
For more information about QuidelOrtho and their work in diagnostics, please visit their official website.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.